Janus Henderson Group
TCON

Janus Henderson Group’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Janus Henderson Group’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-32
Closed -$63K – 850
2015
Q3 		$63K Sell
32
-923
-97% -$2.16M ﹤0.01% 825
2015
Q2 		$504K Hold
955
– – ﹤0.01% 781
2015
Q1 		$2.68M Buy
+955
New +$2.51M 0.02% 468

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.66B AUM 14.89% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Janus Henderson Group's TCON Position: Q4 2015 in Review

Janus Henderson Group sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q4 2015, closing a stake of 32 shares — an estimated $63K sold.

Janus Henderson Group first reported a position in TCON in Q1 2015 and held it in 3 quarters. The position peaked at $2.68M in Q1 2015. 23 funds tracked by Wall St. Rank hold TCON as of Q4 2015.

  • Janus Henderson Group reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Janus Henderson Group sold 32 TRACON Pharmaceuticals, Inc. Common Stock shares in Q4 2015, an estimated $63K.
  • Janus Henderson Group first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 3 quarters.
  • Janus Henderson Group's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $2.68M in Q1 2015.
  • 23 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2015.

Based on Janus Henderson Group's 13F filing for Q4 2015, filed 3 Feb 2016.